2m 2m 2m 2m 2m 2m 2m
Cerus (CERS)
NASDAQ
$2.47-$0.03 (-1.00%)
Price as of Sep 11, 2026 7:30 PM EDT- $501.8MMarket Cap
- 102.44%1-Year Change
- Medical DevicesIndustry
Cerus (CERS)
$2.47-$0.03 (-1.00%)
CERS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.49 | ||
Change | +$0.03 (+1.22%) | ||
Open | $2.50 | ||
High | $2.51 | ||
Low | $2.45 | ||
Previous Close | $2.46 | ||
Volume | 1,545,740 | ||
30-Day Average Volume | 1,646,004 | ||
1-Week Change | -3.86% | ||
1-Month Change | -2.92% | ||
1-Year Change | 102.44% | ||
3-Year Change | 48.21% | ||
5-Year Change | -59.90% | ||
Fundamentals | |||
Shares Outstanding | 201.5M | ||
Total Assets | $205.2M | ||
Market Cap | $501.8M | ||
Enterprise Value | $548.7M | ||
Period: QTR TTM FY | |||
Revenue | $57.4M | ||
Net Income | -$2.9M | ||
Free Cash Flow | -$3.5M | ||
EBIT | -$2.8M | ||
EBITDA | -$2.4M | ||
Net Working Capital | $71.5M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -230 | ||
Enterprise Value/Revenue | 10 | ||
P/B | 7 | ||
P/E | -249 | ||
PEG | N/A | ||
Price/Free Cash Flow | -142 | ||
Price/Operating Cash Flow | -189 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue